PGNYProgyny, Inc.

$34.84+87% 1Y
Latest close: a new 52-week highNov 6, 2026what changed →

Price

+87%1Y

End-of-day closes, not the intraday tick.

What they do

Progyny is a global leader in women’s health and family building solutions. We envision a world where everyone can realize their dreams of family and ideal health. Our mission is to empower healthier, supported journeys through transformative fertility, family building and women’s health benefits. Through our differentiated approach to benefits plan design, member education and support and active network management, our clients’ employees are able to pursue the most effective treatment across life’s milestones from the best providers and specialists and achieve optimal outcomes.

In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR

P/E32.0
Market value$2.57B
1 year+87%
5 years-44%

Charts

As reported to the SEC, without any scoring.

Business segments

Q3 2026 · $341.3M

The company’s own SEC segment disclosure.

  • Fertility benefit services$223.4M65%
  • Pharmacy benefit services$117.9M35%

Progyny, Inc. (PGNY) reported revenue of $341M in Q3 2026 (quarter ended Sep 30, 2026), up 8.9% from the same quarter a year earlier. That came with a gross margin of 25% and net income of $26M (7.7% of revenue). For the full year FY2025, revenue was $1.29B (+10% year on year) and net income $59M. Its largest product in Q3 2026 was Fertility benefit services at $223M, 65% of the disclosed total, well ahead of Pharmacy benefit services at 35%. The next results filing is expected around Feb 3, 2027, a quarter after the last one.

What the company said

The company's own words from its current reports to the SEC, newest first

  1. Nov 4, 2026Progyny, Inc. Announces Third Quarter 2026 Results.Earnings release · press release
  2. Aug 6, 2026Progyny, Inc. Announces Second Quarter 2026 Results.Earnings release · press release
  3. May 27, 2026Progyny, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on May 21, 2026. At the Annual Meeting, the Company’s stockholders approved certain amendments (the “Charter Amendments”) to the Company’s Certificate of Incorporation.Charter/bylaw amendment or fiscal-year change · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.